Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Rubinstein

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Drug Discovery Today. Technologies|July 2, 2014
Colonic drug deliveryAbraham Rubinstein
Critical Reviews in Therapeutic Drug Carrier Systems|June 26, 2003
The colon as a possible target for orally administered peptide and protein drugsSusan Haupt, Abraham Rubinstein
International Journal of Pharmaceutics|April 23, 2021
Controlling the release rate of topotecan from PLGA spheres and increasing its cytotoxicity towards glioblastoma cells by co-loading with calcium chlorideRacheli Sharon Gabbay, Abraham Rubinstein
International Journal of Pharmaceutics|June 23, 2022
Synchronizing the release rates of topotecan and paclitaxel from a self-eroding crosslinked chitosan - PLGA platformRacheli Sharon Gabbay, Abraham Rubinstein
Bioconjugate Chemistry|July 20, 2006
Chitosan-pentaglycine-phenylboronic acid conjugate: a potential colon-specific platform for calcitoninReem Smoum, Abraham Rubinstein, Morris Srebnik
Bioorganic Chemistry|November 14, 2003
A study of the effect on nucleophilic hydrolytic activity of pancreatic elastase, trypsin, chymotrypsin, and leucine aminopeptidase by boronic acids in the presence of arabinogalactan: a subsequent study on the hydrolytic activity of chymotrypsin by boronic acids in the presence of mono-, di-, and trisaccharidesReem Smoum, Abraham Rubinstein, Morris Srebnik
Organic & Biomolecular Chemistry|February 26, 2005
Noncovalent inhibition of the serine proteases, alpha-chymotrypsin and trypsin by trifluoro(organo)boratesReem Smoum, Abraham Rubinstein, Morris Srebnik
International Journal of Pharmaceutics|August 29, 2017
Increasing the affinity of cationized polyacrylamide-paclitaxel nanoparticles towards colon cancer cells by a surface recognition peptideSanjay Tiwari, Boaz Tirosh, Abraham Rubinstein
Pharmaceutical Research|April 9, 2004
Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomesTareq Taha Jubeh, Yechezkel Barenholz, Abraham Rubinstein
Pharmaceutical Research|September 21, 2002
The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cellsAyelet David, Pavla Kopecková, Jindrich Kopecek, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Drug Discovery Today. Technologies|July 2, 2014
Colonic drug deliveryAbraham Rubinstein
Critical Reviews in Therapeutic Drug Carrier Systems|June 26, 2003
The colon as a possible target for orally administered peptide and protein drugsSusan Haupt, Abraham Rubinstein
International Journal of Pharmaceutics|April 23, 2021
Controlling the release rate of topotecan from PLGA spheres and increasing its cytotoxicity towards glioblastoma cells by co-loading with calcium chlorideRacheli Sharon Gabbay, Abraham Rubinstein
International Journal of Pharmaceutics|June 23, 2022
Synchronizing the release rates of topotecan and paclitaxel from a self-eroding crosslinked chitosan - PLGA platformRacheli Sharon Gabbay, Abraham Rubinstein
Bioconjugate Chemistry|July 20, 2006
Chitosan-pentaglycine-phenylboronic acid conjugate: a potential colon-specific platform for calcitoninReem Smoum, Abraham Rubinstein, Morris Srebnik
Bioorganic Chemistry|November 14, 2003
A study of the effect on nucleophilic hydrolytic activity of pancreatic elastase, trypsin, chymotrypsin, and leucine aminopeptidase by boronic acids in the presence of arabinogalactan: a subsequent study on the hydrolytic activity of chymotrypsin by boronic acids in the presence of mono-, di-, and trisaccharidesReem Smoum, Abraham Rubinstein, Morris Srebnik
Organic & Biomolecular Chemistry|February 26, 2005
Noncovalent inhibition of the serine proteases, alpha-chymotrypsin and trypsin by trifluoro(organo)boratesReem Smoum, Abraham Rubinstein, Morris Srebnik
International Journal of Pharmaceutics|August 29, 2017
Increasing the affinity of cationized polyacrylamide-paclitaxel nanoparticles towards colon cancer cells by a surface recognition peptideSanjay Tiwari, Boaz Tirosh, Abraham Rubinstein
Pharmaceutical Research|April 9, 2004
Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomesTareq Taha Jubeh, Yechezkel Barenholz, Abraham Rubinstein
Pharmaceutical Research|September 21, 2002
The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cellsAyelet David, Pavla Kopecková, Jindrich Kopecek, et al.
Pageof 4